In relation to pharmacovigilance (PV), choose the correct option. A After drug registration, the benefit-risk assessment reports must be made by ...

In relation to pharmacovigilance (PV), choose the correct option.


A After drug registration, the benefit-risk assessment reports must be made by the regulatory agencies.
B PV monitors the drug safety only through the assessment of adverse reactions due to overdose.
C The reporting of drug reactions to authorities must only be done by health care institutions.
D A drug’s lack of efficacy and misuse of heath products are relevant to PV.